Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Carolyn M. Boudreau, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
Science Immunology (2022) Vol. 8, Iss. 79
Open Access | Times Cited: 172
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 122
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Paulina Kapłonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Immunity (2022) Vol. 55, Iss. 2, pp. 355-365.e4
Open Access | Times Cited: 100
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
Recent updates on correlates of vaccine-induced protection
Stanley A. Plotkin
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 42
Maternal immune protection against infectious diseases
Stephanie N. Langel, Maria Blasi, Sallie R. Permar
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 660-674
Open Access | Times Cited: 40
An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses
Jingdi Pan, Qihui Wang, Mi Qi, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13474-13487
Closed Access | Times Cited: 29
Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine
Erik S. Pena, Cole J. Batty, Dylan A. Hendy, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123836-123836
Closed Access | Times Cited: 7
The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens
Hillary A. Vanderven, Stephen J. Kent
Immunology and Cell Biology (2020) Vol. 98, Iss. 4, pp. 253-263
Open Access | Times Cited: 51
Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination
Julianna Han, Aaron J. Schmitz, Sara T. Richey, et al.
Cell Reports (2021) Vol. 34, Iss. 4, pp. 108682-108682
Open Access | Times Cited: 45
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Kathryn Bowman, Daniel Stein, Sally Shin, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 29
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
Paulina Kapłonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1161-1172
Open Access | Times Cited: 17
Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
Xiaogang Tong, R. P. McNamara, María José Avendaño, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Primary nasal influenza infection rewires tissue-scale memory response dynamics
Samuel W. Kazer, Colette Matysiak Match, Erica M. Langan, et al.
Immunity (2024) Vol. 57, Iss. 8, pp. 1955-1974.e8
Closed Access | Times Cited: 6
More antibodies are not always better: Fc effector functions play a critical role in SARS-CoV-2 infection and protection
Alberto Rubio‐Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
Progress in molecular biology and translational science (2025)
Closed Access
Non-neutralizing Antibodies Directed at Conservative Influenza Antigens
Е. С. Седова, D. N. Scherbinin, А. А. Лысенко, et al.
Acta Naturae (2019) Vol. 11, Iss. 4, pp. 22-32
Open Access | Times Cited: 42
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
Leonie M. Weskamm, Anahita Fathi, Matthijs P. Raadsen, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100685-100685
Open Access | Times Cited: 22
Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines
Chunhong Dong, Wandi S. Zhu, Lai Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
Charles D. Murin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 32
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
Mengling Li, Pengju Guo, Cen Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Selective transfer of maternal antibodies in preterm and fullterm children
Sepideh Dolatshahi, Audrey L. Butler, Christian Pou, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
Vicky Roy, Wonyeong Jung, Caitlyn Linde, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Next-Generation Influenza Vaccines
Masaru Kanekiyo, Barney S. Graham
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 8, pp. a038448-a038448
Open Access | Times Cited: 29
Antibody-mediated NK cell activation as a correlate of immunity against influenza infection
Carolyn M. Boudreau, John S. Burke, Ashraf S. Yousif, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses
Willemijn Rijnink, Daniel Stadlbauer, Eduard Puente‐Massaguer, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top